Updated May 2008

   
 

The Journal of Investigational Allergology & Clinical Immunology will consider for publication those papers directly related to allergology and clinical and experimental immunopathology.
In general, the journal subscribes to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (henceforth the Uniform Requirements) of the International Committee of Medical Journal Editors (ICMJE): http://www.icmje.org . Further specifications follow.

The Journal will comprise the following major sections:

Original Articles. Original research papers in allergy and
immunopathology, new forms of therapy for allergic and immune
disorders, new applications of diagnostic methods, and clinical and
experimental studies on the immunopathogenesis of allergic diseases and
immune disorders are welcome. Note that a report of a case series may
be considered an original article only if there is an explicit objective that
motivated the retrospective or prospective (cohort) study, which should
include appropriate statistical treatment of the data.
Advice on appropriate sectioning of original articles can be found
in the ICMJE’s Uniform Requirements. In those requirements, it is also
recommended that certain study designs follow particular structures for
optimum reporting; links to those specific recommendations can be obtained
from the ICMJE website. They are the CONSORT statement for randomized
controlled trials, the STARD statement for studies of diagnostic accuracy, the
QUOROM statement for systematic reviews and meta-analyses of trials, the
STROBE statement for observational studies, and the MOOSE statement for
systematic analyses and meta-analyses of observational studies.

Case Reports. A report is a description of a single case or a small
series of cases illustrating exceptional results. Case report sections are as
follows: introduction, case description, discussion. Maximum length is
1500 words, not including abstract, figure legends, or references (please
supply a word count); up to 3 figures and/or tables will be accepted. For
guidance on acceptable handling of photographs and other safeguards
of patient confidentiality and anonymity, refer to section II.E.1 of the
ICMJE’s Uniform Requirements: Patients and Study Participants.
References are limited to 20.

Short Communications and Brief Case Notes. These short papers,
which are intended for rapid publication, follow the same structures as
longer original articles or case reports described above but do not use
subheadings or include an abstract. The text is strictly limited to less than
600 words (please supply a word count), up to 10 references, 1 figure or
table, and up to 5 key words.

Editorials and Review Articles. Contributions from specialists in the
field are requested by the Editors. Unsolicited reviews will be subject
to consideration by the Editorial Board or subject to peer review at the
Board’s discretion.

Letters to the Editor. Comments on articles published in J Investig
Allergol Clin Immunol
are welcome. The letter will be sent to the author
of the related article, who will have 4 weeks to answer. After the reply, no
further correspondence will be accepted. Letters will be reviewed by the
Editorial Board or subject to peer review at the Board’s discretion

Submission of Manuscripts

Manuscripts can be submitted as a Microsoft Word fi le or a rich text
format (RTF) fi le by e-mail to the editorial office: jiaci@unav.es . File names should include the corresponding author’s surname. Each figure
should be in a separate document, and the fi le name for each should
include the corresponding author’s surname and a key word that indicates
the figure number and manuscript it pertains to.

Author Assurances. A cover letter requesting review by the Editorial
Board for publication in the journal should accompany the manuscript and
include a statement by the authors(s) confirming that the manuscript has not
been published elsewhere and is not under consideration for publication
elsewhere, as well as a statement of consent from all the authors.
All manuscripts accepted for publication remain the property of the
J Investig Allergol Clin Immunol and are subject to copyright restrictions
regarding reproduction. Manuscripts published in or submitted to another
journal cannot be considered.

Preparation of Manuscripts

Manuscripts should be typewritten, double-spaced with ample margins
on all sides, and with numbered pages, following the ICMJE Uniform
Requirements. The word limits for the body of the text, not including
abstract, figure legends, or references are as follows: original articles, 3500
words; reviews 7500; case reports, 1500; short communications, brief case
notes and letters, 600. (Please supply a word count on the title page.)

Title Page. The first page should contain the full title, a brief running title
(not to exceed 40 characters), full name of author(s), institutional affiliation
of author(s), and name, mailing address, fax and e-mail of the author to
whom all correspondence should be directed. Note the word count and the
number of tables and figures. If data have been presented in abstract or poster
form at conferences, this information should be noted after the title page, as
should funding sources for the study or any author conflicts of interest.

Abstract. Original articles, case reports and reviews require abstracts.
The major points of the article should be summarized in 150 (case reports)
to 250 words (original and review articles), in the order of their appearance
in the manuscript. Material or facts not cited in the full manuscript should
not be included in the abstract. The abstract of an original article should
be organized with the following subheadings: Background (optional),
Objective(s), Methods (or Material and Methods or Patients and Methods,
as appropriate), Results, Conclusion(s). Such structuring is unnecessary
for reviews and case reports.

Key Words. Three to 8 key words or brief phrases should be included
after the abstract for indexing purposes. The Medical Subject Headings
used by the US National Library of Medicine’s Index Medicus (MEDLINE)
are preferred.

Main Text. For original articles, authors should follow the ICMJE
Uniform Requirements for structuring their articles into sections and
subsections, as mentioned above.
As the ICMJE does not describe the content of case reports, we
offer the following guidance: the introduction describes the relevance
of the clinical entity and ends with a brief characterization of the
case; the case description section gives a chronological account of the
presentation, diagnosis, clinical course and outcomes; the discussion
section frames the case in a concise review of the literature and may
suggest implications.

Tables. Each table should be typed on a separate page after the
references. Authors are requested, whenever possible, to construct tables
that can be arranged on the page and read in the same direction as the text. Titles should not exceed two lines. Information appearing in fi gures
or text should not be included in tables.

Figures. Figures should illustrate important results, and they should
be cited in the text. Line artwork (such as graphs) should be submitted
as TIFF files, with a minimum resolution of 800 dpi. Other artwork
(such as photographs) should be submitted as 250-300 dpi TIFF fi les.
Legends should be included on a separate page in the manuscript, after
the references.

Acknowledgments. When necessary, credit should be given to
persons, centers or foundations who have collaborated in the study.
Please also acknowledge help received in preparation of the manuscript
(editing services, translation, or other) or statistical analysis. Refer to
advice in the ICMJE’s Uniform Requirements.

References. All references should be numbered consecutively
throughout the text and enclosed in square brackets placed before
punctuation. Journal abbreviations in the reference list should be those
of the US National Library of Medicine’s Index Medicus. (See a few
examples below.) Complete citation of all the author(s) name(s) should
be followed by the complete title of the paper, abbreviated journal title,
year, volume, and first and last page number. When citing a chapter
from a book, the author(s) name(s) should be followed by the complete
title of the paper, title of the book, volume number, editor(s) name(s),
address and name of the publisher, year, and first and last page numbers:
References (with the exception of review articles) should be limited to
approximately 35 for original articles and approximately 20 for case
reports.
Authors should not submit manuscripts in which Microsoft Word
footnoting tools have been used to insert references; if other reference
management software is used, authors should remove the hyperlinks
before submitting the manuscript.
Following are 3 examples of reference presentation forms. For
additional examples, see the US National Library of Medicine’s complete
list: http://www.nlm.nih.gov/bsd/uniform_requirements.html .

1. Parameswaran K, Radford K, Zuo J, Janssen LJ, O’Byrne PM,
Cox PG. Extracellular matrix regulates human airway smooth
muscle cell migration. Eur Respir J. 2004;24:545-51.

2. Global Initiative for Asthma. Global Strategy for Asthma
Management and Prevention NIH Pub. No 02-3659, January
1995. Updated 2005. [cited 2006 Oct 24]. Available from: www.
ginasthma.com.

3. Marsh DG. Genetic and molecular analysis of human immune
responsiveness to allergens. In: Marsh DG, Lockhart A, Holgate
ST, editors. The genetics of asthma. Oxford: Blackwell Scientific
Publications; 1993. p. 201-13.

Copyediting and Proofreading

The corresponding author will be contacted by a copyeditor while
the manuscript is being prepared for publication, so that the author can
approve any modifications suggested. Furthermore, the corresponding
author will receive the copyedited manuscript by e-mail with proposed
modifications marked on the fi le, for approval or correction. This process
should ensure that the manuscript is both correct and readable, to the
author’s satisfaction. If the author is unavailable during this process,
publication delay may result.
A minimal number of changes should be necessary on page proofs,
which will be sent to the same corresponding author a few weeks later.
Proofs, particularly tables and figures, should be checked against the original
manuscript. Authors will be charged for major alterations in the original text,
so attention should be given during the copyediting phase. Proofs not returned
in time to meet the publication date will either be rescheduled or published
without the authors’ corrections, in which case the Editors do not assume
responsibility for any errors that might have been made in typesetting.

   

Top